We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Pliva Gets Warning Letter for CGMP Violations
Pliva Gets Warning Letter for CGMP Violations
May 8, 2006
The FDA issued a warning letter April 28 to Croatian drug firm Pliva for a variety of manufacturing violations at its Zagreb, Croatia plant. The letter was posted on the FDA’s website May 5.